Vanguard Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-6,282,173
| Closed | -$428M | – | 4626 |
|
|
2022
Q3 | $428M | Buy |
6,282,173
+262,742
| +4% | +$17.9M | 0.01% | 920 |
|
|
2022
Q2 | $192M | Sell |
6,019,431
-4,831
| -0.1% | -$154K | 0.01% | 1443 |
|
|
2022
Q1 | $209M | Buy |
6,024,262
+31,120
| +0.5% | +$1.08M | ﹤0.01% | 1529 |
|
|
2021
Q4 | $175M | Buy |
5,993,142
+178,743
| +3% | +$5.23M | ﹤0.01% | 1688 |
|
|
2021
Q3 | $148M | Sell |
5,814,399
-48,220
| -0.8% | -$1.23M | ﹤0.01% | 1770 |
|
|
2021
Q2 | $205M | Buy |
5,862,619
+285,864
| +5% | +$10M | 0.01% | 1620 |
|
|
2021
Q1 | $227M | Buy |
5,576,755
+116,273
| +2% | +$4.74M | 0.01% | 1519 |
|
|
2020
Q4 | $236M | Buy |
5,460,482
+132,907
| +2% | +$5.76M | 0.01% | 1369 |
|
|
2020
Q3 | $294M | Sell |
5,327,575
-192,011
| -3% | -$10.6M | 0.01% | 1028 |
|
|
2020
Q2 | $348M | Sell |
5,519,586
-8,609
| -0.2% | -$543K | 0.01% | 936 |
|
|
2020
Q1 | $282M | Buy |
5,528,195
+56,733
| +1% | +$2.9M | 0.01% | 934 |
|
|
2019
Q4 | $435M | Sell |
5,471,462
-138,128
| -2% | -$11M | 0.01% | 897 |
|
|
2019
Q3 | $272M | Buy |
5,609,590
+243,464
| +5% | +$11.8M | 0.01% | 1145 |
|
|
2019
Q2 | $282M | Buy |
5,366,126
+485,866
| +10% | +$25.6M | 0.01% | 1142 |
|
|
2019
Q1 | $258M | Buy |
4,880,260
+275,458
| +6% | +$14.6M | 0.01% | 1178 |
|
|
2018
Q4 | $189M | Buy |
4,604,802
+402,359
| +10% | +$16.5M | 0.01% | 1278 |
|
|
2018
Q3 | $160M | Buy |
4,202,443
+108,137
| +3% | +$4.11M | 0.01% | 1540 |
|
|
2018
Q2 | $185M | Buy |
4,094,306
+231,569
| +6% | +$10.5M | 0.01% | 1399 |
|
|
2018
Q1 | $187M | Buy |
3,862,737
+586,252
| +18% | +$28.3M | 0.01% | 1329 |
|
|
2017
Q4 | $129M | Buy |
3,276,485
+65,708
| +2% | +$2.59M | 0.01% | 1588 |
|
|
2017
Q3 | $99.7M | Buy |
3,210,777
+277,526
| +9% | +$8.62M | ﹤0.01% | 1715 |
|
|
2017
Q2 | $80.2M | Buy |
2,933,251
+397,271
| +16% | +$10.9M | ﹤0.01% | 1788 |
|
|
2017
Q1 | $93.5M | Buy |
2,535,980
+726,366
| +40% | +$26.8M | ﹤0.01% | 1684 |
|
|
2016
Q4 | $26.1M | Buy |
1,809,614
+335,414
| +23% | +$4.85M | ﹤0.01% | 2298 |
|
|
2016
Q3 | $34M | Buy |
1,474,200
+195,736
| +15% | +$4.51M | ﹤0.01% | 2112 |
|
|
2016
Q2 | $21.2M | Buy |
1,278,464
+443,440
| +53% | +$7.36M | ﹤0.01% | 2306 |
|
|
2016
Q1 | $13.2M | Buy |
835,024
+331,365
| +66% | +$5.26M | ﹤0.01% | 2466 |
|
|
2015
Q4 | $16.3M | Buy |
503,659
+454,940
| +934% | +$14.7M | ﹤0.01% | 2394 |
|
|
2015
Q3 | $2.05M | Buy |
+48,719
| New | +$2.05M | ﹤0.01% | 3367 |
|